Literature DB >> 21262086

Addressing issues in health technology assessment promotion: Motives, enablers, and barriers.

Abinaya Rajan1, Iñaki Gutierrez-Ibarluzea, Montse Moharra.   

Abstract

OBJECTIVES: The aim of this study was to analyze the motives, enablers, and barriers to promote or initiate health technology assessment (HTA) in different contexts.
METHODS: An observational study design was used to address the above question that included a survey questionnaire and a two-phase study. The respondents for the questionnaire and first round of the study were from HTA agencies of high income countries and those low and middle income countries that have managed to establish HTA agencies (n = 50), that are members of International Network of Agencies for Health Technology Assessment (INAHTA), EuroScan, or European network for Health Technology Assessment (EUnetHTA). The second round of the study was exclusively with respondents from low and middle income countries that were manly affiliated to Health Technology Assessment International (HTAi) interest subgroup for low and middle income countries and aimed to initiate HTA activities (n = 34).
RESULTS: Forty-one of fifty HTA agencies answered the survey questionnaire. Thirty-three of fifty individuals belonging to HTA agencies from high income countries and sixteen of thirty-four individuals from low and middle income countries answered in the first and second phases of the study, respectively. In the promotion and/or initiation of HTA, the top three motives were the same for both high income and low and middle income countries. The top three enablers were also similar but the prioritization varies. The top three barriers were more context specific.
CONCLUSIONS: HTA promotion or initiation is influenced by the following: (i) key players that affect the time taken to establish HTA agencies; (ii) three models for HTA promotion and initiation: top-down (political interest), bottom-up (academic/research interest), and converging (political and academic/research interests); and (iii) motives, enablers, and barriers at the local context.

Mesh:

Year:  2011        PMID: 21262086     DOI: 10.1017/S0266462310001352

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  5 in total

Review 1.  Access to cancer medications in low- and middle-income countries.

Authors:  Gilberto de Lima Lopes; Jonas A de Souza; Carlos Barrios
Journal:  Nat Rev Clin Oncol       Date:  2013-04-09       Impact factor: 66.675

2.  Health technology assessment in Iran: Barriers and solutions.

Authors:  Farideh Mohtasham; Bahareh Yazdizadeh; Zahra Zali; Reza Majdzadeh; Sima Nedjat
Journal:  Med J Islam Repub Iran       Date:  2016-01-26

3.  Cost effectiveness of breast cancer screening using mammography; a systematic review.

Authors:  Arash Rashidian; Eshagh Barfar; Hamed Hosseini; Shirin Nosratnejad; Esmat Barooti
Journal:  Iran J Public Health       Date:  2013-04-01       Impact factor: 1.429

4.  HTA and MCDA solely or combined? The case of priority-setting in Colombia.

Authors:  Héctor E Castro; Ornella Moreno-Mattar; Juan C Rivillas
Journal:  Cost Eff Resour Alloc       Date:  2018-11-09

5.  Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis.

Authors:  Samantha Hollingworth; Ama Pokuaa Fenny; Su-Yeon Yu; Francis Ruiz; Kalipso Chalkidou
Journal:  Cost Eff Resour Alloc       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.